Buy HUMA by Jan 10, 2026.

This DD on HUMA requires the reader to be a bit off mentally. So I couldn't think of a better stage than this dumpster fire of a sub (behind Wendy's). After rimming the $10 level this summer, the stock has settled under $5 despite [FDA approval.](https://investors.humacyte.com/news-releases/news-release-details/humacyte-announces-fda-approval-symvesstm-acellular-tissue) Some say FDA approval was more than priced-in, but what's important is to look at how the stock got here from $10 and what the company's prospects look like in comparison to its Enterprise …